Mahshid Mohseni, MD
NPI 1356634612 · Endocrinology, Diabetes & Metabolism Physician · Saint Louis, MO
Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1356634612
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- 2016023799 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,946 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Dxa Bone Density Measurement of Hip, Pelvis, Spine77080 | 970 | $36 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 660 | $14 |
| Calculation of Trabecular Bone Score (tbs) Using Imaging Data With Interpretation and Report on Fracture Risk77089 | 581 | $38 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 368 | $123 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 192 | $87 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Alendronate Sodium | 390 | 112 |
| Teriparatidebrand: Forteo | 79 | 15 |
| Abaloparatidebrand: Tymlos | 64 | 11 |
| Ergocalciferol (vitamin D2)brand: Vitamin D2 | 54 | 20 |
| Levothyroxine Sodium | 50 | 11 |
| Teriparatide | 45 | — |
| Pen Needle, Diabeticbrand: Ultra-Fine Mini Pen Needle | 31 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$94 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2011-05-19
- Last updated
- 2025-04-17
- Certified
- 2024-08-18
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.